Cargando…

Statin Use and Eligibility for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Adults at Borderline or Intermediate Risk in the United States

Detalles Bibliográficos
Autores principales:	Hammond, Michael M., Cameron, Natalie A., Ning, Hongyan, Bah, Imani, Beltrame, Kaitlyn, Khan, Sadiya S., Shah, Nilay S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227278/ https://www.ncbi.nlm.nih.gov/pubmed/37026554 http://dx.doi.org/10.1161/JAHA.122.029263

Ejemplares similares

Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016
por: Yao, Xiaoxi, et al.
Publicado: (2020)

Polypill for atherosclerotic cardiovascular disease prevention in Haiti: Eligibility estimates in a low-income country
por: Yan, Lily D., et al.
Publicado: (2022)

Role of Statins in the Primary Prevention of Atherosclerotic Cardiovascular Disease and Mortality in the Population with Mean Cholesterol in the Near-Optimal to Borderline High Range: A Systematic Review and Meta-Analysis
por: Singh, Bishnu M., et al.
Publicado: (2020)

Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults
por: Guo, Yi, et al.
Publicado: (2020)

The association of atherosclerotic cardiovascular disease and statin use with inflammation and treatment outcomes in tuberculosis
por: Chidambaram, Vignesh, et al.
Publicado: (2021)

Trends in Cardiovascular Mortality Related to Atrial Fibrillation in the United States, 2011 to 2018
por: Tanaka, Yoshihiro, et al.
Publicado: (2021)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Association between statin therapy and mortality in patients on dialysis after atherosclerotic cardiovascular diseases
por: Lee, Myunhee, et al.
Publicado: (2023)

The Prevalence of Potential Prescribing Omissions for Antiplatelets and Statins in Older Adults With Atherosclerotic Cardiovascular Disease
por: Alshehri, Samah, et al.
Publicado: (2023)

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)

Cardiovascular Risk Stratification and Statin Eligibility Based on the Brazilian vs. North American Guidelines on Blood Cholesterol Management
por: Cesena, Fernando Henpin Yue, et al.
Publicado: (2017)

Reclassification of Cardiovascular Risk Based on the Presence of Carotid Plaque Regarding Statin Eligibility in Low to Moderate Risk Patients
por: Park, Chan Seok
Publicado: (2022)

Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015)

Controlling the thickness of the atherosclerotic plaque by statin medication
por: Formanowicz, Dorota, et al.
Publicado: (2020)

Underuse of statins for secondary prevention of atherosclerotic cardiovascular disease events among ambulatory surgical patients
por: Schonberger, Robert B., et al.
Publicado: (2020)

Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
por: Kao, Yu-Cheng, et al.
Publicado: (2021)

Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi‐Ethnic Study of Atherosclerosis)
por: Miedema, Michael D., et al.
Publicado: (2018)

Inflammation in atherosclerotic cardiovascular disease
por: Shah, Prediman K., et al.
Publicado: (2019)

Diabetes-Related Cardiovascular and All-Cause Mortality in Asian American Subgroups
por: Shah, Nilay S., et al.
Publicado: (2023)

Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2021)

Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease
por: Moon, Gyeong Joon, et al.
Publicado: (2014)

Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis
por: Boettiger, David C, et al.
Publicado: (2020)

Eligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study
por: Moon, Byung Sub, et al.
Publicado: (2016)

Statin Eligibility and Outpatient Care Prior to ST‐Segment Elevation Myocardial Infarction
por: Miedema, Michael D., et al.
Publicado: (2017)

Association of Social Network Characteristics With Cardiovascular Health and Coronary Artery Calcium in South Asian Adults in the United States: The MASALA Cohort Study
por: Shah, Nilay S., et al.
Publicado: (2021)

Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
por: Li, Yi-Heng, et al.
Publicado: (2020)

Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen
por: Al-Ashwal, Fahmi Y., et al.
Publicado: (2022)

Trends and outcome of statin therapy in dialysis patients with atherosclerotic cardiovascular diseases: A population-based cohort study
por: Lee, Myunhee, et al.
Publicado: (2023)

Trends in heart failure-related cardiovascular mortality in rural versus urban United States counties, 2011–2018: A cross-sectional study
por: Pierce, Jacob B., et al.
Publicado: (2021)

Dialogue: Vitamin D, statins and atherosclerotic progression in paediatric lupus
por: Gilkeson, Gary, et al.
Publicado: (2015)

Plasma Aldosterone Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive Patients for Atherosclerotic Cardiovascular Disease
por: Lin, Jui-Hsiang, et al.
Publicado: (2018)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
por: Wang, Miao, et al.
Publicado: (2020)

Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System
por: Dorsch, Michael P., et al.
Publicado: (2019)

Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis
por: Boettiger, David C., et al.
Publicado: (2021)

Using deep learning-based natural language processing to identify reasons for statin nonuse in patients with atherosclerotic cardiovascular disease
por: Sarraju, Ashish, et al.
Publicado: (2022)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
por: Zheutlin, Alexander R., et al.
Publicado: (2022)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
por: Ryou, In Sun, et al.
Publicado: (2022)

Cardiovascular Health Among Pregnant Women, Aged 20 to 44 Years, in the United States
por: Perak, Amanda M., et al.
Publicado: (2020)

Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins
por: McQueen, R. Brett, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_psad1m9kq1qftheqpn4ace939o